ECDC welcomes the endorsement of the global action plan on antimicrobial resistance by the World Health Assembly
By endorsing the new global action plan endorsed at the World Health Assembly, WHO Member States agreed to mobilise resources to ensure its implementation and committed to have similar plans at national level by 2017.
On 25 May, delegates from the World Health Assembly, the decision-making body of the World Health Organisation (WHO), endorsed a global action plan to tackle antimicrobial resistance. The goal of this action plan is to ensure successful treatment and prevention of infectious diseases by securing fair, affordable access to effective antimicrobial agents to those who need it most. The global action plan defines five objectives to achieve this goal:
- to improve awareness and understanding of antimicrobial resistance;
- to strengthen knowledge through surveillance and research;
- to reduce the incidence of infection;
- to optimise the use of antimicrobial agents; and
- to develop the economic case for sustainable investment that takes account of the needs of all countries, and increase investment in new medicines, diagnostic tools, vaccines and other interventions.
Through adoption of the global action plan, WHO Member States agreed to mobilise resources to ensure its implementation and committed to have similar plans at national level by 2017. Several EU/EEA Member States, the EU (European Council, European Commission) and WHO/Europe, already have strategies or action plans to tackle antimicrobial resistance. These were listed on the ECDC directory page of online resources for prevention and control of antimicrobial resistance and healthcare-associated infections.
Whole genome sequencing: new ECDC framework suggests priority diseases and implementation options
4 Apr 2019 - Whole genome sequencing (WGS) is a fast-moving technology, but the pace of change vary between pathogens/diseases and European Union countries. In a new report, ECDC proposes to prioritise the implementation of WGS depending on disease and public health application.
Extensively drug-resistant gonorrhoea: risk of further dissemination within and across Europe
1 Apr 2019 - ECDC comment on the study 'Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018' by Eyre et al. in the Eurosurveillance edition of 7 March 2019.
Strong laboratory leaders - a key asset for global disease control
28 Mar 2019 - Laboratories play an essential role in the detection, diagnosis, prevention and control of diseases. To strengthen this role, ECDC and five partner organisations have developed the Global Laboratory Leadership Programme (GLLP) to support and sustain national laboratory systems under a One Health approach.